Please ensure Javascript is enabled for purposes of website accessibility

3 Great Stocks for Low-Risk Investors

By Joe Tenebruso - Apr 2, 2017 at 7:05AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These businesses prove that high risk is not always a requirement for investment rewards.

Sophisticated investors define risk as the possibility that an investment will result in a permanent loss of capital. One of the best ways to dampen risk, therefore, is to invest in businesses with diverse revenue streams and steady cash flows that can be counted upon in all manner of market environments. The three businesses that follow excel in this regard.

Perhaps no other company is as broadly diversified as legendary investor Warren Buffett's jewel, Berkshire Hathaway (BRK.A 0.97%) (BRK.B 0.99%). The megaconglomerate owns more than 60 different subsidiaries spanning industries as varied as insurance, utilities, railroads, and retail businesses, among others. This broad sector diversification helps make Berkshire able to withstand even the most turbulent market conditions.

In fact, it's during these volatile times that Berkshire is best able to deploy its massive cash reserves into value-creating investments. One example is Buffett's purchase of $5 billion worth of Bank of America (BAC 2.57%) preferred stock during the depths of the financial crisis. That purchase also included warrants to purchase 700 million shares of Bank of America common stock for $7.14 a share at any time before Sept. 2021. At current prices, those warrants are worth around $11 billion, meaning that Berkshire's investment in Bank of America has already more than tripled in value. And with $86 billion in cash on Berkshire's balance sheet, Buffett remains on the prowl for new investments that could create even more wealth for the company and its shareholders.

Warren Buffett

Warren Buffett. Image source: The Motley Fool.

Impressively, even at age 86, Buffett continues to learn and grow as an investor. After mostly shunning the technology sector for decades, Buffett recently took a massive stake in tech titan Apple. And although he (wisely) avoided the major airlines for much of Berkshire's existence, Buffett recently disclosed investments in several airline stocks after consolidation reshaped the competitive dynamics of this once beleaguered industry. This ability to adapt to a changing investment landscape further lessens Berkshire's risk, and strengthens the company's ability to deliver excellent long-term returns to its investors.

Budweiser beer

Image source: Anheuser-Busch InBev.

Anheuser-Busch InBev (BUD -0.36%) is the undisputed king of beer. After its recent $100 billion acquisition of SABMiller -- its former No. 1 competitor -- AB InBev's portfolio of more than 500 beers commands nearly 30% of the global beer market, including seven of the top 10 global beer brands.

AB InBev's strength lies in its unmatched distribution system. The company sells its beers in more than 150 countries, making it the world's first truly global brewer. This broad geographic footprint helps to reduce AB InBev's risk profile, in that sluggish sales in some areas of the world can be offset by stronger results in others. For instance, the merger with SABMiller has strengthened the company's presence in high-growth emerging markets like Africa, which are helping to offset tepid sales in countries currently struggling with economic woes, such as Brazil.

The risk to AB InBev's growth-through-acquisition strategy is further lessened by its proven track record of operational success. The company excels at slashing costs and boosting profits at the businesses it acquires. In this way, AB InBev is able to create long-term value for its shareholders, even after acquiring these companies at substantial premiums. That's a rare ability, one that -- when combined with its dominant presence in many of the world's emerging markets -- helps to make Anheuser-Busch InBev an excellent stock to own in the years, and even century, ahead.

Boxes of Band-Aid bandages

Image source: The Motley Fool.

Johnson & Johnson (JNJ -0.21%) is another great low-risk business with highly diversified revenue streams. The healthcare giant's empire spans three broad segments -- pharmaceuticals, medical devices, and consumer products -- and comprises more than 250 operating businesses in 60 countries.

Moreover, the majority of products that Johnson & Johnson sells benefit from steady, repeat purchases. Regardless of what's happening in the economy, people get sick, need medicine, and require medical procedures. This relatively stable demand helps Johnson & Johnson churn out consistent sales and profits through all types of market environments:

JNJ Revenue (Annual) Chart

JNJ Revenue (Annual) data by YCharts.

Additionally, Johnson & Johnson's strong cash flow generation -- combined with its more than $40 billion in cash reserves -- allows it to invest aggressively in research and development, as well as in the acquisition of promising new drugs and technologies. In 2016, J&J's $71.9 billion in revenue produced $15.5 billion in free cash flow, which in turn allowed it to allocate more than $9 billion to R&D and $5 billion to acquisitions and licensing deals. These moves help to further fortify J&J's already strong pipeline and position the company for continued growth. It's a powerful virtuous cycle -- cash flow is directed to value-creating research and acquisitions, which help to generate more cash, which can be reinvested, and so on -- that has served Johnson & Johnson's shareholders well for decades, and that should continue to do so for decades to come.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$177.92 (-0.21%) $0.38
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
BRK.A
$418,159.34 (0.97%) $4,011.32
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
BRK.B
$278.37 (0.99%) $2.72
Bank of America Corporation Stock Quote
Bank of America Corporation
BAC
$31.77 (2.57%) $0.80
Anheuser-Busch InBev SA/NV Stock Quote
Anheuser-Busch InBev SA/NV
BUD
$54.59 (-0.36%) $0.20

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
322%
 
S&P 500 Returns
113%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.